Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15442727 | 0.98 | CA1 (0.48) | CA1ACE2ZDHHC7TSHRFAAH | |
| SCHEMBL15443307 | 0.98 | CA1 (0.48) | CA1ACE2ZDHHC7TSHRFAAH | |
| SCHEMBL12158831 | 0.94 | TSHR (0.45) | CA1ACE2TSHRHPGDFDPS | |
| Acetic Acid SCHEMBL27948184 | 0.93 | ACE2 (0.45) | CA1ACE2ZDHHC7TSHRFAAH | |
| Ethane SCHEMBL27996835 | 0.93 | TSHR (0.44) | CA1ACE2TSHRHPGDFDPS | |
| SCHEMBL6910529 | 0.86 | TSHR (0.36) | CA1TSHRHPGDFDPS | |
| Ethane SCHEMBL20838520 | 0.85 | SMN1; SMN2 (0.36) | CA1TSHRHPGDFDPS | |
| SCHEMBL28144331 | 0.83 | ZDHHC7 (0.42) | CA1ZDHHC7TSHRHPGDFAAH | |
| SCHEMBL3617251 | 0.81 | CA1 (0.50) | CA1ACE2ZDHHC7FAAHFDPS | |
| SCHEMBL491649 | 0.81 | ZDHHC7 (0.44) | ZDHHC7TSHRHPGDFAAHABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0402771-B1 | Process for the enzymatic clearance of 2-arylpropionic acid vinyl esters | HOECHST AG (DE) | 1994-11-30 | — | — | EP | claimed |
| US-5155028-A | Incubation, enyzmatic hydrolysis; stereoselective; antiinflammatory agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-13 | — | — | US | claimed |
| JP-3043095-A | — | — | None | — | — | JP | disclosed |
| JP-3043095-A | — | — | None | — | — | JP | disclosed |
| CN-117820535-A | Soft vinyl chloride copolymer, process for producing the same, vinyl chloride resin composition, and resin product | 北京化工大学 | 2024-04-05 | — | — | CN | disclosed |
| CN-117801151-A | Hard vinyl chloride copolymer, method for producing the same, vinyl chloride resin composition, and resin product | 北京化工大学 | 2024-04-02 | — | — | CN | disclosed |
| US-20230110863-A1 | THERMOSETTING RESIN COMPOSITION AND TRANSESTERIFICATION REACTION CATALYST | KYOEISHA CHEMICAL CO., LTD. (JP) | 2023-04-13 | — | — | US | disclosed |
| US-11618816-B2 | Method for forming a multilayer coating film and multilayer coating film | KYOEISHA CHEMICAL CO., LTD. (JP) | 2023-04-04 | — | — | US | disclosed |
| US-20230087596-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | KYOEISHA CHEMICAL CO., LTD. (JP) | 2023-03-23 | — | — | US | disclosed |
| EP-4098696-A1 | THERMOSETTING RESIN COMPOSITION AND TRANSESTERIFICATION REACTION CATALYST | Kyoeisha Chemical Co., Ltd. (JP) | 2022-12-07 | — | — | EP | disclosed |
| US-11442373-B2 | Liquid electrostatic ink composition | HP INDIGO B.V. (NL) | 2022-09-13 | — | — | US | disclosed |
| CN-103477492-A | Non-aqueous electrolyte solution and electricity-storage device using same | UBE INDUSTRIES | 2013-12-25 | — | — | CN | disclosed |
| US-5426211-A | Antiinflammaatory agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |
| US-5426211-A | Antiinflammaatory agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |
| EP-0402771-B1 | Process for the enzymatic clearance of 2-arylpropionic acid vinyl esters | HOECHST AG (DE) | 1994-11-30 | — | — | EP | disclosed |
| US-5155028-A | Incubation, enyzmatic hydrolysis; stereoselective; antiinflammatory agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-13 | — | — | US | disclosed |
| US-5155028-A | Incubation, enyzmatic hydrolysis; stereoselective; antiinflammatory agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-10-13 | — | — | US | disclosed |
| JP-H0343095-A | ENZYMATIC CLEAVAGE OF VINYL 2-ARYLPROPIONATE | HOECHST AG | 1991-02-25 | — | — | JP | disclosed |
| JP-H0343095-A | ENZYMATIC CLEAVAGE OF VINYL 2-ARYLPROPIONATE | HOECHST AG | 1991-02-25 | — | — | JP | disclosed |
| EP-0402771-A1 | Process for the enzymatic clearance of 2-arylpropionic acid vinyl esters | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230087596-A1 | ESTER COMPOUND, METHOD FOR PRODUCING SAME, POLYMER, THERMOSETTING RESIN COMPOSITION AND CURED FILM | RER1, EMG1, SETDB1 | CA1 2359/4885ACE2 4351/4885ZDHHC7 1732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.